Skip to main content
. 2020 Nov 11;12(7):564–569. doi: 10.1136/flgastro-2020-101579

Figure 2.

Figure 2

Number of pharmaceutical industry sponsored studies on adult patients per JLA-IBD research priority since 9 August 2016 in the UK (n=63). JLA-IBD, James Lind Alliance-inflammatory bowel disease.